The present invention relates generally to medical devices used for accessing, visualizing, and/or treating regions of tissue within a body. More particularly, the present invention relates to methods and apparatus for integrating solid state camera systems, such as CMOS imaging systems, into an imaging system to visualize tissue.
Conventional devices for visualizing interior regions of a body lumen are known. For example, ultrasound devices have been used to produce images from within a body in vivo. Ultrasound has been used both with and without contrast agents, which typically enhance ultrasound-derived images.
Other conventional methods have utilized catheters or probes having position sensors deployed within the body lumen, such as the interior of a cardiac chamber. These types of positional sensors are typically used to determine the movement of a cardiac tissue surface or the electrical activity within the cardiac tissue. When a sufficient number of points have been sampled by the sensors, a “map” of the cardiac tissue may be generated.
Another conventional device utilizes an inflatable balloon which is typically introduced intravascularly in a deflated state and then inflated against the tissue region to be examined. Imaging is typically accomplished by an optical fiber or other apparatus such as electronic chips for viewing the tissue through the membrane(s) of the inflated balloon. Moreover, the balloon must generally be inflated for imaging. Other conventional balloons utilize a cavity or depression formed at a distal end of the inflated balloon. This cavity or depression is pressed against the tissue to be examined and is flushed with a clear fluid to provide a clear pathway through the blood.
However, such imaging balloons have many inherent disadvantages. For instance, such balloons generally require that the balloon be inflated to a relatively large size which may undesirably displace surrounding tissue and interfere with fine positioning of the imaging system against the tissue. Moreover, the working area created by such inflatable balloons are generally cramped and limited in size. Furthermore, inflated balloons may be susceptible to pressure changes in the surrounding fluid. For example, if the environment surrounding the inflated balloon undergoes pressure changes, e.g., during systolic and diastolic pressure cycles in a beating heart, the constant pressure change may affect the inflated balloon volume and its positioning to produce unsteady or undesirable conditions for optimal tissue imaging. Additionally, imaging balloons are subject to producing poor or blurred tissue images if the balloon is not firmly pressed against the tissue surface because of intervening blood between the balloon and tissue.
Accordingly, these types of imaging modalities are generally unable to provide desirable images useful for sufficient diagnosis and therapy of the endoluminal structure, due in part to factors such as dynamic forces generated by the natural movement of the heart. Moreover, anatomic structures within the body can occlude or obstruct the image acquisition process. Also, the presence and movement of opaque bodily fluids such as blood generally make in vivo imaging of tissue regions within the heart difficult.
Other external imaging modalities are also conventionally utilized. For example, computed tomography (CT) and magnetic resonance imaging (MRI) are typical modalities which are widely used to obtain images of body lumens such as the interior chambers of the heart. However, such imaging modalities fail to provide real-time imaging for intra-operative therapeutic procedures. Fluoroscopic imaging, for instance, is widely used to identify anatomic landmarks within the heart and other regions of the body. However, fluoroscopy fails to provide an accurate image of the tissue quality or surface and also fails to provide for instrumentation for performing tissue manipulation or other therapeutic procedures upon the visualized tissue regions. In addition, fluoroscopy provides a shadow of the intervening tissue onto a plate or sensor when it may be desirable to view the intraluminal surface of the tissue to diagnose pathologies or to perform some form of therapy on it.
Thus, a tissue imaging system which is able to provide real-time in vivo images of tissue regions within body lumens such as the heart through opaque media such as blood and which also provide instruments for therapeutic procedures upon the visualized tissue are desirable.
A tissue imaging and manipulation apparatus that may be utilized for procedures within a body lumen, such as the heart, in which visualization of the surrounding tissue is made difficult, if not impossible, by medium contained within the lumen such as blood, is described below. Generally, such a tissue imaging and manipulation apparatus comprises an optional delivery catheter or sheath through which a deployment catheter and imaging hood may be advanced for placement against or adjacent to the tissue to be imaged.
The deployment catheter may define a fluid delivery lumen therethrough as well as an imaging lumen within which an optical imaging fiber or assembly may be disposed for imaging tissue. When deployed, the imaging hood may be expanded into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area or field is defined by the imaging hood. The open area is the area within which the tissue region of interest may be imaged. The imaging hood may also define an atraumatic contact lip or edge for placement or abutment against the tissue region of interest. Moreover, the distal end of the deployment catheter or separate manipulatable catheters may be articulated through various controlling mechanisms such as push-pull wires manually or via computer control
The deployment catheter may also be stabilized relative to the tissue surface through various methods. For instance, inflatable stabilizing balloons positioned along a length of the catheter may be utilized, or tissue engagement anchors may be passed through or along the deployment catheter for temporary engagement of the underlying tissue.
In operation, after the imaging hood has been deployed, fluid may be pumped at a positive pressure through the fluid delivery lumen until the fluid fills the open area completely and displaces any blood from within the open area. The fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, Fluorinert™, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid. The fluid may be pumped continuously or intermittently to allow for image capture by an optional processor which may be in communication with the assembly.
In an exemplary variation for imaging tissue surfaces within a heart chamber containing blood, the tissue imaging and treatment system may generally comprise a catheter body having a lumen defined therethrough, a visualization element disposed adjacent the catheter body, the visualization element having a field of view, a transparent fluid source in fluid communication with the lumen, and a barrier or membrane extendable from the catheter body to localize, between the visualization element and the field of view, displacement of blood by transparent fluid that flows from the lumen, and an instrument translatable through the displaced blood for performing any number of treatments upon the tissue surface within the field of view. The imaging hood may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools which may be deployed through the deployment catheter.
More particularly in certain variations, the tissue visualization system may comprise components including the imaging hood, where the hood may further include a membrane having a main aperture and additional optional openings disposed over the distal end of the hood. An introducer sheath or the deployment catheter upon which the imaging hood is disposed may further comprise a steerable segment made of multiple adjacent links which are pivotably connected to one another and which may be articulated within a single plane or multiple planes. The deployment catheter itself may be comprised of a multiple lumen extrusion, such as a four-lumen catheter extrusion, which is reinforced with braided stainless steel fibers to provide structural support. The proximal end of the catheter may be coupled to a handle for manipulation and articulation of the system.
To provide visualization, an imaging element such as a fiberscope or electronic imager such as a solid state camera, e.g., CCD or CMOS, may be mounted, e.g., on a shape memory wire, and positioned within or along the hood interior. A fluid reservoir and/or pump (e.g., syringe, pressurized intravenous bag, etc.) may be fluidly coupled to the proximal end of the catheter to hold the translucent fluid such as saline or contrast medium as well as for providing the pressure to inject the fluid into the imaging hood.
In an exemplary variation for imaging tissue surfaces, this application further shows various embodiments of the tissue visualization catheter with high resolution miniature imaging systems integrated into or along the imaging hood. Such miniature imaging systems can comprise solid state cameras enabled by CMOS (complementary metal oxide semi-conductors) or CCD (charged couple devices) technology where elements of the imaging device may be separated from one another and inter-connected by appropriate cable(s). Integrating the solid state cameras within or along the imaging hood allows for the imagers to be compacted into a small volume having a low profile and/or a flexible configuration.
Miniature imaging systems integrated within the tissue visualization catheter may be also arranged to provide off-axis visualization of imaged tissue surfaces distal to the imaging hood when opaque bodily fluids such as blood are purged from the hood. As compared to axially-oriented visualization along the axis of the catheter (for example, optical fibers positioned within a working channel of a catheter), off-axis visualization utilizing integrated solid state imagers may be particularly advantageous in allowing operators to view and gauge distances between deployed tools and tissue. Given the low-profile configuration of the imaging assembly, any number of instruments may be passed within the visual field of the hood for treating the underlying tissue. Off-axis visualization may also be particularly advantageous in providing visual confirmation of instrument-to-tissue contact as compared to axially-oriented visualization.
One or more light sources, e.g., light emitting diodes (LEDs), may also be surface mounted along the imaging assembly or separately in any number of configurations. For example, LEDs may be positioned circumferentially around the interior of the imaging hood on one or more hood support struts to provide illumination for the space defined by the imaging hood. Illumination from multiple light sources from different positions and angles provided by the plurality of light sources may facilitate imaging by preventing glare which may be caused by reflected light when visualizing illuminated tissue surfaces through the imaging hood. Moreover, illumination with this configuration may reduce shadow effects when tools are introduced into the hood.
A tissue-imaging and manipulation apparatus described herein is able to provide real-time images in vivo of tissue regions within a body lumen such as a heart, which is filled with blood flowing dynamically therethrough and is also able to provide intravascular tools and instruments for performing various procedures upon the imaged tissue regions. Such an apparatus may be utilized for many procedures, e.g., facilitating transeptal access to the left atrium, cannulating the coronary sinus, diagnosis of valve regurgitation/stenosis, valvuloplasty, atrial appendage closure, arrhythmogenic focus ablation, among other procedures.
One variation of a tissue access and imaging apparatus is shown in the detail perspective views of
When the imaging and manipulation assembly 10 is ready to be utilized for imaging tissue, imaging hood 12 may be advanced relative to catheter 14 and deployed from a distal opening of catheter 14, as shown by the arrow. Upon deployment, imaging hood 12 may be unconstrained to expand or open into a deployed imaging configuration, as shown in
Imaging hood 12 may be attached at interface 24 to a deployment catheter 16 which may be translated independently of deployment catheter or sheath 14. Attachment of interface 24 may be accomplished through any number of conventional methods. Deployment catheter 16 may define a fluid delivery lumen 18 as well as an imaging lumen 20 within which an optical imaging fiber or assembly may be disposed for imaging tissue. When deployed, imaging hood 12 may expand into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area or field 26 is defined by imaging hood 12. The open area 26 is the area within which the tissue region of interest may be imaged. Imaging hood 12 may also define an atraumatic contact lip or edge 22 for placement or abutment against the tissue region of interest. Moreover, the diameter of imaging hood 12 at its maximum fully deployed diameter, e.g., at contact lip or edge 22, is typically greater relative to a diameter of the deployment catheter 16 (although a diameter of contact lip or edge 22 may be made to have a smaller or equal diameter of deployment catheter 16). For instance, the contact edge diameter may range anywhere from 1 to 5 times (or even greater, as practicable) a diameter of deployment catheter 16.
As seen in the example of
Although contact edge 22 need not directly contact the underlying tissue, it is at least preferably brought into close proximity to the tissue such that the flow of clear fluid 28 from open area 26 may be maintained to inhibit significant backflow of blood 30 back into open area 26. Contact edge 22 may also be made of a soft elastomeric material such as certain soft grades of silicone or polyurethane, as typically known, to help contact edge 22 conform to an uneven or rough underlying anatomical tissue surface. Once the blood 30 has been displaced from imaging hood 12, an image may then be viewed of the underlying tissue through the clear fluid 30. This image may then be recorded or available for real-time viewing for performing a therapeutic procedure: The positive flow of fluid 28 may be maintained continuously to provide for clear viewing of the underlying tissue. Alternatively, the fluid 28 may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point the fluid flow 28 may cease and blood 30 may be allowed to seep or flow back into imaging hood 12. This process may be repeated a number of times at the same tissue region or at multiple tissue regions.
In utilizing the imaging hood 12 in any one of the procedures described herein, the hood 12 may have an open field which is uncovered and clear to provide direct tissue contact between the hood interior and the underlying tissue to effect any number of treatments upon the tissue, as described above. Yet in additional variations, imaging hood 12 may utilize other configurations. An additional variation of the imaging hood 12 is shown in the perspective and end views, respectively, of
Aperture 42 may function generally as a restricting passageway to reduce the rate of fluid out-flow from the hood 12 when the interior of the hood 12 is infused with the clear fluid through which underlying tissue regions may be visualized. Aside from restricting out-flow of clear fluid from within hood 12, aperture 42 may also restrict external surrounding fluids from entering hood 12 too rapidly. The reduction in the rate of fluid out-flow from the hood and blood in-flow into the hood may improve visualization conditions as hood 12 may be more readily filled with transparent fluid rather than being filled by opaque blood which may obstruct direct visualization by the visualization instruments.
Moreover, aperture 42 may be aligned with catheter 16 such that any instruments (e.g., piercing instruments, guidewires, tissue engagers, etc.) that are advanced into the hood interior may directly access the underlying tissue uninhibited or unrestricted for treatment through aperture 42. In other variations wherein aperture 42 may not be aligned with catheter 16, instruments passed through catheter 16 may still access the underlying tissue by simply piercing through membrane 40.
In an additional variation,
Additional details of tissue imagine and manipulation systems and methods which may be utilized with apparatus and methods described herein are further described, for example, in U.S. patent application Ser. No. 11/259,498 filed Oct. 25, 2005 (U.S. Pat. Pub. No. 2006/0184048 A1); Ser. No. 11/763,399 filed Jun. 14, 2007 (U.S. Pat. Pub. No. 2007/0293724 A1); and also in Ser. No. 11/828,267 filed Jul. 25, 2007 (U.S. Pat. Pub. No. 2008/0033290 A1), each of which is incorporated herein by reference in its entirety.
In imaging the underlying tissue for diagnosis and/or treatment, optical fiberscopes may be positioned within the deployment catheter to view the tissue from an axial orientation in-line with a longitudinal axis of the catheter and/or imaging hood. Alternatively, other variations may utilize high resolution imaging systems integrated into the imaging hood. Such imaging systems can include solid state cameras utilizing CMOS (complementary metal oxide semi-conductors) or CCD (charged couple devices) technology where elements of the imaging device may be separated from one another and interconnected by pin connectors or cables such that the imaging assembly may be mounted within or along an inner surface of the imaging hood. Such configurations may also allow the solid state cameras to be compacted into a relatively small volumes with low profiles and/or a flexible configurations.
Generally, such a solid state electronic imaging system may comprise in one variation a lens assembly, an electronic imaging sensor positioned adjacent to the lens assembly for receiving an image from the lens assembly, and a video processing assembly electrically coupled to the imaging sensor via a flexible connector where the imaging system is sized to be positioned within or along an inner surface of an imaging hood which is reconfigurable between a delivery profile and a deployment profile. In use, the imaging assembly may be intravascularly advanced by a deployment catheter to the tissue region of interest where the imaging assembly may be reconfigured from a delivery profile to a deployment profile such that the imaging assembly defines an open area in fluid communication with a fluid lumen defined through the catheter. Once reconfigured into the deployed profile, the open area of the device may be positioned against the tissue region such that blood is displaced from the open area and the tissue may then be visualized, e.g., via the off-axis electronic imaging assembly positioned within or along an inner surface of the imaging assembly.
As aforementioned, when tissue is visualized via a fiberscope, the field of view 52 provided by the fiberscope is limited to an axially oriented image relative to the longitudinal axis of the catheter 16, as illustrated in the side view of
In utilizing the electronic solid state imaging element, e.g., CMOS imager or camera, the imaging assembly positioned within the visualization and/or treatment assembly 70 may be electrically coupled to control assembly 78 through deployment catheter 16 and handle 72. The variation illustrated in the assembly of
In this variation, the lens assembly and image sensors of the electronic imaging assembly may be located within visualization and/or treatment assembly 70 while separated from the remaining circuitry. The remaining circuitry may include a video processing board 86 and power supply board 80 that can be housed in control assembly 78. The power supply board 80 may be electrically coupled to the rest of the imaging assembly via power conductor 82 while the video processing board 86 may be coupled via image signal conductor 88. Grounding conductor 84 may also be coupled within control assembly 78. The control assembly 78 can communicate with the miniature CMOS camera in the imaging hood 12 via connection cables coupling the CMOS camera, through the work channel of catheter 16, through handle 72, and into the control assembly 78.
An example illustrating the relative positioning within CMOS imaging assembly 110 mounted along the inner surface of imaging hood 12 is shown in the exploded perspective assembly view of
In either case, the images captured through optional prism 114 and lens assembly 112 may be projected onto the imaging sensor 116 or 118 which may convert the images to electrical signals for transmission through image signal conductor 124 back to the control assembly. Power may be supplied to the image sensor through power conductor 120 and the image sensor may also be connected to grounding conductor 122. With the image sensors ranging in size as small as 1 mm in diameter and by further separating elements of the CMOS imaging system 110 and integrating these separate elements into the visualization catheter, a compact imaging element can be mounted onto the imaging hood 12 without the need to compromise on image resolution normally available through the use of imaging modalities such as fiberoptics.
In another variation,
Yet another variation is illustrated in the exploded perspective assembly view of integrated CMOS imaging assembly 170 in
In yet another variation,
The imaging system described may also be incorporated into other catheter control systems, for example, as shown in the perspective views of
Additionally, such planarly configured and flexible CMOS imaging systems may be utilized in other catheter systems such as those described in U.S. Pat. Pub. No. 2004/0006333 A1, which is also incorporated herein by reference in their entirety. The visualization balloon can be transparent to visualize tissue through opaque fluids such as blood and can be at least partially transmissive to ablation energy, such as laser energy.
The applications of the disclosed invention discussed above are not limited to certain treatments or regions of the body, but may include any number of other treatments and areas of the body. Modification of the above-described methods and devices for carrying out the invention, and variations of aspects of the invention that are obvious to those of skill in the arts are intended to be within the scope of this disclosure. Moreover, various combinations of aspects between examples are also contemplated and are considered to be within the scope of this disclosure as well.
This application claims the benefit of priority to U.S. Prov. Pat. App. 60/952,476 filed Jul. 27, 2007, which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
60952476 | Jul 2007 | US |